Geode Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.2M Buy
619,547
+7,194
+1% +$989K 0.01% 1121
2025
Q1
$110M Buy
612,353
+20,757
+4% +$3.74M 0.01% 923
2024
Q4
$92.7M Sell
591,596
-35
-0% -$5.48K 0.01% 1053
2024
Q3
$108M Buy
591,631
+11,411
+2% +$2.08M 0.01% 947
2024
Q2
$107M Buy
580,220
+54,475
+10% +$10M 0.01% 885
2024
Q1
$93.6M Buy
525,745
+14,499
+3% +$2.58M 0.01% 957
2023
Q4
$63.4M Buy
511,246
+28,011
+6% +$3.48M 0.01% 1188
2023
Q3
$56.1M Buy
483,235
+38,975
+9% +$4.52M 0.01% 1156
2023
Q2
$52.2M Buy
444,260
+13,689
+3% +$1.61M 0.01% 1209
2023
Q1
$34.5M Buy
430,571
+18,444
+4% +$1.48M ﹤0.01% 1442
2022
Q4
$32.6M Buy
412,127
+12,865
+3% +$1.02M ﹤0.01% 1445
2022
Q3
$27.8M Buy
399,262
+13,887
+4% +$968K ﹤0.01% 1511
2022
Q2
$25.3M Buy
385,375
+20,085
+5% +$1.32M ﹤0.01% 1591
2022
Q1
$24.3M Buy
365,290
+35,364
+11% +$2.35M ﹤0.01% 1761
2021
Q4
$23.1M Buy
329,926
+12,318
+4% +$862K ﹤0.01% 1854
2021
Q3
$16.6M Sell
317,608
-2,568
-0.8% -$134K ﹤0.01% 2086
2021
Q2
$21.8M Buy
320,176
+34,343
+12% +$2.34M ﹤0.01% 1902
2021
Q1
$22M Buy
285,833
+47,126
+20% +$3.63M ﹤0.01% 1818
2020
Q4
$14.3M Buy
238,707
+29,766
+14% +$1.79M ﹤0.01% 1920
2020
Q3
$8.99M Buy
208,941
+28,595
+16% +$1.23M ﹤0.01% 2004
2020
Q2
$7.47M Buy
180,346
+13,451
+8% +$557K ﹤0.01% 2106
2020
Q1
$7.22M Buy
166,895
+20,112
+14% +$870K ﹤0.01% 1932
2019
Q4
$8.13M Buy
146,783
+3,387
+2% +$188K ﹤0.01% 2156
2019
Q3
$4.98M Buy
143,396
+23,629
+20% +$820K ﹤0.01% 2381
2019
Q2
$4.82M Buy
119,767
+48,069
+67% +$1.94M ﹤0.01% 2417
2019
Q1
$2.36M Buy
71,698
+11,095
+18% +$365K ﹤0.01% 2761
2018
Q4
$1.26M Buy
60,603
+24,137
+66% +$501K ﹤0.01% 3009
2018
Q3
$641K Hold
36,466
﹤0.01% 3376
2018
Q2
$542K Buy
+36,466
New +$542K ﹤0.01% 3413